Found: 10
Select item for more details and to access through your institution.
Comparison of Body Composition Changes Between Atazanavir/Ritonavir and Lopinavir/Ritonavir Each in Combination with Tenofovir/Emtricitabine in Antiretroviral-Naïve Patients with HIV-1 Infection.
- Published in:
- Clinical Drug Investigation, 2014, v. 34, n. 4, p. 287, doi. 10.1007/s40261-014-0175-4
- By:
- Publication type:
- Article
Changes in Body Composition with Ritonavir-Boosted and Unboosted Atazanavir Treatment in Combination with Lamivudine and Stavudine: A 96-Week Randomized, Controlled Study.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 9, p. 1323, doi. 10.1086/597776
- By:
- Publication type:
- Article
Clinical Significance of Hyperbilirubinemia Among HIV-1-Infected Patients Treated with Atazanavir/Ritonavir Through 96 Weeks in the CASTLE Study.
- Published in:
- AIDS Patient Care & STDs, 2012, v. 26, n. 5, p. 259, doi. 10.1089/apc.2011.0092
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Atazanavir-containing Antiretroviral Regimens, with or without Ritonavir, in Patients who are HIV-positive and Treatment-naïve.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 3, p. 284, doi. 10.1002/phar.1205
- By:
- Publication type:
- Article
Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 2, p. 465, doi. 10.1093/jac/dkr490
- By:
- Publication type:
- Article
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 2, p. 363, doi. 10.1093/jac/dkq457
- By:
- Publication type:
- Article
Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study.
- Published in:
- PLoS ONE, 2010, v. 5, n. 6, p. 1, doi. 10.1371/journal.pone.0010952
- By:
- Publication type:
- Article
Suitable Monitoring Approaches to Antiretroviral Therapy in Resource-Poor Settings: Setting the Research Agenda.
- Published in:
- Clinical Infectious Diseases, 2003, v. 37, p. S13, doi. 10.1086/375368
- By:
- Publication type:
- Article
Adenovirus Infection in Adult Orthotopic Liver Transplant Recipients: Incidence and Clinical Significance.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 459, doi. 10.1086/517375
- By:
- Publication type:
- Article
Rimegepant 75 mg for acute treatment of migraine is associated with significant reduction in monthly migraine days: Results from a long-term, open-label study.
- Published in:
- Cephalalgia Reports, 2022, v. 5, p. 1, doi. 10.1177/25158163221075596
- By:
- Publication type:
- Article